Wordt geladen...
WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy
Intrinsic resistance to cytotoxic T-lymphocyte (CTL) killing limits responses to immune activating anti-cancer therapies. Here, we established that activation of the G2/M cell cycle checkpoint results in tumor cell cycle pause and protection from granzyme B-induced cell death. This was reversed with...
Bewaard in:
| Gepubliceerd in: | Oncoimmunology |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6169577/ https://ncbi.nlm.nih.gov/pubmed/30288354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1488359 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|